You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / ERIS LIFESCIENCES

ERIS LIFESCIENCES
Intrinsic Value | Fundamental Analysis

Returns | 1W : -1.9% , 1M : -6.7%,1Y : 18.5%
BOM : 540596     NSE : ERIS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Average
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Apr 19,2021
Price(EOD): Rs. 580.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 7,882.51 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
ERIS LIFESCIENCES -1.9% -6.7% 18.5%
SUN PHARMACEUTICAL INDUSTRIES 3.4% 6.4% 39.2%
DR REDDYS LABORATORIES -0.4% 11.7% 26.7%
DIVIS LABORATORIES 0.6% 12.6% 59.7%
CIPLA 4.8% 19.4% 56.3%
BIOCON 0.6% 3.5% 18%
AUROBINDO PHARMA 5.4% 14.8% 74.8%
LUPIN 1.5% 0.6% 27.8%
TORRENT PHARMACEUTICALS 1.6% 5% 12.5%

FUNDAMENTAL ANALYSIS OF ERIS LIFESCIENCES

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than ERIS LIFESCIENCES Premium


VALUATION OF ERIS LIFESCIENCES

 
Valuation Score
RatioValue
P/E
P/B
P/S
27.06
P/E Calculated based on EPS of 21.45
[ Mar2020 - Standalone Results ]

6.08
P/B Calculated based on Book Value of 95.51
[ Mar2020 - Standalone Results ]

7.73
P/S Calculated based on Revenues of 1019.39 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than ERIS LIFESCIENCES Premium


FAIR VALUE OF ERIS LIFESCIENCES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-10%
-39%
-22%

SHARE PRICE MOMENTUM OF ERIS LIFESCIENCES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0.15
0.43
0.19
0
0.15
0.44
0.2
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-5.35%
-12.73%
-13.78%
-15.98%
12.92%
29.12%
37.13%
41.42%
QtrlyTrend
0
Latest Qtr: Dec2020

ERIS LIFESCIENCES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 2.5% 9.5% 53.4%
S&P BSE 150 MIDCAP 0.9% -2.8% 85.3%
S&P BSE 400 MIDSMALLCAP 0.6% -3.4% 88.9%
S&P BSE MIDSMALLCAP 0.6% -2.9% 87.1%
S&P BSE SMALL CAP 0.6% -2.3% 99.4%
S&P BSE 250 LARGEMIDCAP 0.5% -3.4% 64.7%
S&P BSE ALLCAP 0.5% -3.5% 67.3%
S&P BSE 500 0.5% -3.5% 66.4%
NSE Indices1W1M1Y
NIFTY 500 0.4% -3.5% 65.9%
NIFTY MID SMALL400 0.4% -3.6% 89.2%
NIFTY SMALLCAP250 0.2% -4.1% 100.5%
NIFTY LARGE MIDCAP 250 -2.2% -1.4% 73.1%

FAQ [Frequently Asked Questions]


Is ERIS good for long term investment?

As on 19-Apr-2021, the Fundamentals of ERIS are Strong and hence it's good for long term investment! See Financial Performance of ERIS LIFESCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ERIS UnderValued or OverValued?

As on 19-Apr-2021, ERIS is Under Valued and hence a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ERIS ?

As on 19-Apr-2021, the Intrinsic Value of ERIS is Rs. 741.65 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 648.26
Fair Value [Median EV / Sales Model] : Rs. 945.73
Fair Value [Median Price / Sales Model] : Rs. 741.65
Median Fair Value of ERIS : Rs. 741.65

Is ERIS trading at a Premium or Discount?

As on 19-Apr-2021, ERIS is trading at a Discount of -22% based on the Median Intrinsic Value!

Is it right time to buy ERIS shares?

As on 19-Apr-2021, ERIS is Under Valued and hence a good buying opportunity according to Share Valuation at this time!
One can wait for the Share Price Momentum to become bullish before entering the stock!

What is the Financial Performance of Industry Peers of ERIS?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with ERIS?

ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
ERIS LIFESCIENCES LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z